You are here: All Products  > Arbele Starts Australian Trial of CDH17xCD3 Bispecific for GI Cancers

Arbele Starts Australian Trial of CDH17xCD3 Bispecific for GI Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products